Terms: = Liver cancer AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105
47 results:
1. Wnt/β-catenin signaling regulates amino acid metabolism through the suppression of CEBPA and foxa1 in liver cancer cells.
Nakagawa S; Yamaguchi K; Takane K; Tabata S; Ikenoue T; Furukawa Y
Commun Biol; 2024 Apr; 7(1):510. PubMed ID: 38684876
[TBL] [Abstract] [Full Text] [Related]
2. Hepatocyte-specific HDAC3 ablation promotes hepatocellular carcinoma in females by suppressing foxa1/2.
Xu Y; Zhu Y; Wu Z; Li S; Shao M; Tao Q; Xu Q; Chen Y; Shu Y; Chen M; Zhou Y; Shi Y
BMC Cancer; 2023 Sep; 23(1):906. PubMed ID: 37752418
[TBL] [Abstract] [Full Text] [Related]
3. Determinants of widespread metastases and of metastatic tropism in patients with prostate cancer: A genomic analysis of primary and metastatic tumors.
Alshalalfa M; Goglia AG; Swami N; Nguyen B; Hougen HY; Khan A; Kishan AU; Punnen S; Nguyen PL; Mahal BA; Dee EC
Urol Oncol; 2023 May; 41(5):253.e21-253.e26. PubMed ID: 37003878
[TBL] [Abstract] [Full Text] [Related]
4. MYC determines lineage commitment in KRAS-driven primary liver cancer development.
D'Artista L; Moschopoulou AA; Barozzi I; Craig AJ; Seehawer M; Herrmann L; Minnich M; Kang TW; Rist E; Henning M; Klotz S; Heinzmann F; Harbig J; Sipos B; Longerich T; Eilers M; Dauch D; Zuber J; Wang XW; Zender L
J Hepatol; 2023 Jul; 79(1):141-149. PubMed ID: 36906109
[TBL] [Abstract] [Full Text] [Related]
5. The Fibrotic Effects of LINC00663 in Human Hepatic Stellate LX-2 Cells and in Bile Duct-Ligated Cholestasis Mice Are Mediated through the Splicing Factor 2-Fibronectin.
Chu Y; Bao L; Teng Y; Yuan B; Ma L; Liu Y; Kang H
Cells; 2023 Jan; 12(2):. PubMed ID: 36672150
[TBL] [Abstract] [Full Text] [Related]
6. foxa1/2 depletion drives global reprogramming of differentiation state and metabolism in a human liver cell line and inhibits differentiation of human stem cell-derived hepatic progenitor cells.
Warren I; Moeller MM; Guiggey D; Chiang A; Maloy M; Ogoke O; Groth T; Mon T; Meamardoost S; Liu X; Thompson S; Szeglowski A; Thompson R; Chen P; Paulmurugan R; Yarmush ML; Kidambi S; Parashurama N
FASEB J; 2023 Jan; 37(1):e22652. PubMed ID: 36515690
[TBL] [Abstract] [Full Text] [Related]
7. Elevated foxa1 Expression Indicates Poor Prognosis in liver cancer due to Its Effects on Cell Proliferation and Metastasis.
Liu Z; Wang Y; Aizimuaji Z; Ma S; Xiao T
Dis Markers; 2022; 2022():3317315. PubMed ID: 35968505
[TBL] [Abstract] [Full Text] [Related]
8. CRISPR screening uncovers a central requirement for HHEX in pancreatic lineage commitment and plasticity restriction.
Yang D; Cho H; Tayyebi Z; Shukla A; Luo R; Dixon G; Ursu V; Stransky S; Tremmel DM; Sackett SD; Koche R; Kaplan SJ; Li QV; Park J; Zhu Z; Rosen BP; Pulecio J; Shi ZD; Bram Y; Schwartz RE; Odorico JS; Sidoli S; Wright CV; Leslie CS; Huangfu D
Nat Cell Biol; 2022 Jul; 24(7):1064-1076. PubMed ID: 35787684
[TBL] [Abstract] [Full Text] [Related]
9. Multicenter Study of ACR Ultrasound LI-RADS Visualization Scores on Serial Examinations: Implications for Surveillance Strategies.
Tiyarattanachai T; Fetzer DT; Kamaya A
AJR Am J Roentgenol; 2022 Sep; 219(3):445-452. PubMed ID: 35383486
[No Abstract] [Full Text] [Related]
10. Effect of centralization and regionalization of pancreatic surgery on resection rates and survival.
Latenstein AEJ; Mackay TM; van der Geest LGM; van Eijck CHJ; de Meijer VE; Stommel MWJ; Vissers PAJ; Besselink MG; de Hingh IHJT;
Br J Surg; 2021 Jul; 108(7):826-833. PubMed ID: 33738473
[TBL] [Abstract] [Full Text] [Related]
11. Landmarks to identify segmental borders of the liver: A review prepared for PAM-HBP expert consensus meeting 2021.
Wakabayashi T; Benedetti Cacciaguerra A; Ciria R; Ariizumi S; Durán M; Golse N; Ogiso S; Abe Y; Aoki T; Hatano E; Itano O; Sakamoto Y; Yoshizumi T; Yamamoto M; Wakabayashi G;
J Hepatobiliary Pancreat Sci; 2022 Jan; 29(1):82-98. PubMed ID: 33484112
[TBL] [Abstract] [Full Text] [Related]
12. Opposing Roles of foxa1 and FoxA3 in Intrahepatic Cholangiocarcinoma Progression.
Thanan R; Kaewlert W; Sakonsinsiri C; Chaiprasert T; Armartmuntree N; Muengsaen D; Techasen A; Klanrit P; Lert-Itthiporn W; Pinlaor S; Pairojkul C
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32151057
[TBL] [Abstract] [Full Text] [Related]
13. MicroRNA-3064-5p sponged by MALAT1 suppresses angiogenesis in human hepatocellular carcinoma by targeting the foxa1/CD24/Src pathway.
Zhang P; Ha M; Li L; Huang X; Liu C
FASEB J; 2020 Jan; 34(1):66-81. PubMed ID: 31914639
[TBL] [Abstract] [Full Text] [Related]
14. Integration of Comprehensive Genomic Analysis and Functional Screening of Affected Molecular Pathways to Inform cancer Therapy.
Vasmatzis G; Liu MC; Reganti S; Feathers RW; Smadbeck J; Johnson SH; Schaefer Klein JL; Harris FR; Yang L; Kosari F; Murphy SJ; Borad MJ; Thompson EA; Cheville JC; Anastasiadis PZ
Mayo Clin Proc; 2020 Feb; 95(2):306-318. PubMed ID: 31685261
[TBL] [Abstract] [Full Text] [Related]
15. Trans-acting non-synonymous variant of foxa1 predisposes to hepatocellular carcinoma through modulating foxa1-ERα transcriptional program and may have undergone natural selection.
Wang S; Xiang C; Mou L; Yang Y; Zhong R; Wang L; Sun C; Qin Z; Yang J; Qian J; Zhao Y; Wang Y; Pan X; Qie J; Jiang Y; Wang X; Yang Y; Zhou WP; Miao X; He F; Jin L; Wang H
Carcinogenesis; 2020 Apr; 41(2):146-158. PubMed ID: 31400761
[TBL] [Abstract] [Full Text] [Related]
16. foxa1
Liang J; Tian C; Zeng Y; Yang Q; Liu Y; Liu Y; Wu J; Hu Y; Gu F; Zhang K; Wang Y; Zhang Y; Liu L
Biochem Biophys Res Commun; 2019 Jun; 514(1):308-315. PubMed ID: 31036318
[TBL] [Abstract] [Full Text] [Related]
17. Factors Affecting Interindividual Variability of Hepatic UGT2B17 Protein Expression Examined Using a Novel Specific Monoclonal Antibody.
Émond JP; Labriet A; Desjardins S; Rouleau M; Villeneuve L; Hovington H; Brisson H; Lacombe L; Simonyan D; Caron P; Périgny M; Têtu B; Fallon JK; Klein K; Smith PC; Zanger UM; Guillemette C; Lévesque E
Drug Metab Dispos; 2019 May; 47(5):444-452. PubMed ID: 30819787
[TBL] [Abstract] [Full Text] [Related]
18. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/foxa1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract] [Full Text] [Related]
19. RNF6 facilitates metastasis and radioresistance in hepatocellular carcinoma through ubiquitination of foxa1.
Cai J; Xiong Q; Jiang X; Zhou S; Liu T
Exp Cell Res; 2019 Jan; 374(1):152-161. PubMed ID: 30496760
[TBL] [Abstract] [Full Text] [Related]
20. TXNDC9 promotes hepatocellular carcinoma progression by positive regulation of MYC-mediated transcriptional network.
Chen D; Zou J; Zhao Z; Tang X; Deng Z; Jia J; Liu S
Cell Death Dis; 2018 Oct; 9(11):1110. PubMed ID: 30382079
[TBL] [Abstract] [Full Text] [Related]
[Next]
